Is immunohistochemical staining for β-catenin the definitive pathological diagnostic tool for desmoid-type fibromatosis? A multi-institutional study
Hiroshi Koike(Nagoya University), Naoki Ishiguro(Nagoya University), Tomoya Matsunobu(Kyushu Rosai Hospital), Toshiyuki Kunisada(Okayama University Hospital), Yoshihiro Nishida(Nagoya University), Kei Kohno(Nagoya University Hospital), Koki Shimizu(Nagoya University), Akira Kawai(GTx (United States)), Yoshie Shimoyama(Nagoya University Hospital), Toru Motoi(Tokyo Metropolitan Komagome Hospital), Tabu Gokita, Shunsuke Hamada(Aichi Cancer Center), Akira Ogose(Niigata University Medical and Dental Hospital), Yoshihiro Matsumoto(Jikei University Kashiwa hospital), Tomohisa Sakai(Nagoya University), Keisuke Ae, Toshifumi Ozaki(Okayama University)
Cited by 26
Related Papers
Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
|Annals of Oncology|2021|978
Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2021|558
Bone sarcomas: ESMO–EURACAN–GENTURIS–ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up
|Annals of Oncology|2021|453
Postmarketing surveillance of the safety profile of infliximab in 5000 Japanese patients with rheumatoid arthritis
|Annals of the Rheumatic Diseases|2007|413
Osteosarcoma of the Pelvis: Experience of the Cooperative Osteosarcoma Study Group
|Journal of Clinical Oncology|2003|343